Sign in
4

Changes in Ownership

ClearPoint Neuro, Inc. Filed Acc 0001193125-26-292932

CEO and President sold 20,000 shares at $19.38 ($387,600)

  • CEO and President acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BURNETT JOSEPH CEO and President 2026-06-29 Option exercise 10b5-1 +20,000 $2.50 $50,000 136,842 D: show line 1 in the form
BURNETT JOSEPH CEO and President 2026-06-29 Sale 10b5-1 −20,000 $19.38 $387,600 116,842 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $19.38 · $387,600

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BURNETT JOSEPH CEO and President 2026-06-29 Option exercise · Stock Options (right to buy) 10b5-1 −20,000 250,000 D: show line 3 in the form
Loading xslF345X06/ownership.xml…